首页|期刊导航|海南医科大学学报|消瘀散精简方新组方凝胶贴透皮成分的探究及其对骨关节炎大鼠软骨损伤和滑膜炎的治疗作用

消瘀散精简方新组方凝胶贴透皮成分的探究及其对骨关节炎大鼠软骨损伤和滑膜炎的治疗作用OA

Study on the transdermal components of the new formula gel patch compound of the Xiaoyusan and its therapeutic effect on cartilage injury and synovitis in rats with osteoarthritis

中文摘要英文摘要

目的:研究消瘀散精简方新组方凝胶贴对骨关节炎(osteoarthritis,OA)大鼠的透皮吸收成分以及治疗作用和生物安全性.方法:通过Franz扩散池法模拟皮肤透皮吸收过程,采用超高效液相色谱-高分辨质谱联用方法(UPLC-Q-TOF/MS)对消瘀散精简方新组方凝胶贴透皮接受液进行成分分析;将24只大鼠分为假手术组、OA模型组、阳性对照组(氟比洛芬凝胶贴)、实验组(消瘀散精简方新组方凝胶贴)4组,每组 6只,除假手术组外其余组通过前交叉韧带横断术(anterior cruciate ligment transection,ACLT)建立OA大鼠模型,造模后1周将消瘀散精简方新组方凝胶贴作为实验药物外敷于大鼠膝关节,连续用药21 d后收集眼眶血及膝关节标本,利用苏木精-伊红(hematoxylin-eosin,H&E)染色法和番红-固绿(safranin O-fast green,Safranin O)染色法分析各组大鼠膝关节软骨损伤严重程度;利用H&E染色法评估大鼠膝关节滑膜炎严重程度;采用免疫组化法检测各组软骨中Ⅱ 型胶原(collagen type Ⅱ alpha 1,Col2a1)、基质金属蛋白酶 13(matrix metallopeptidase 13,MMP13)与半胱氨酸蛋白酶3(Caspase 3)的表达及各组滑膜中诱导型一氧化氮合酶(inducible nitric oxide synthase,iNOS)、肿瘤坏死因子-α(tumour necrosis factor alpha,TNF-α)的表达;利用酶联免疫吸附测定(enzyme linked immunosorbent assay,ELISA)分析各组大鼠血清炎症因子TNF-α、白介素-17(interleukin 17,IL-17)水平,利用H&E染色分析各组大鼠组织器官结构评估生物安全性.结果:(1)消瘀散精简方新组方凝胶贴透皮成分含有28种原型成分,包含君药大黄中的 6-甲基-大黄酸、大黄酸.(2)经过21 d外敷治疗后消瘀散精简方新组方凝胶贴与氟比洛芬凝胶贴可治疗OA大鼠关节软骨损伤和滑膜炎症,并且消瘀散精简方新组方凝胶贴的治疗效果更优.消瘀散精简方新组方凝胶贴组大鼠膝关节软骨Col2a1的表达明显上调,MMP13与Caspase 3的表达被明显抑制(P<0.05).(3)应用氟比洛芬凝胶贴膏与消瘀散精简方新组方凝胶贴治疗后能缓解大鼠滑膜炎症,免疫组化染色进一步表明消瘀散精简方新组方凝胶贴组大鼠滑膜TNF-α和iNOS的表达明显下调(P<0.05).(4)ELISA结果表明OA发生、发展过程及消瘀散精简方新组方凝胶贴治疗过程中不会引起全身性的炎症因子TNF-α、IL-17上调,同时消瘀散精简方新组方凝胶贴外敷治疗后各组大鼠组织器官的微观结构正常且无明显炎症浸润.结论:消瘀散精简方新组方凝胶贴透皮成分包含君药大黄中的6-甲基-大黄酸、大黄酸等,消瘀散精简方新组方凝胶贴通过促进关节软骨基质合成,抑制软骨细胞凋亡和滑膜炎症因子表达治疗OA,同时还具有良好生物安全性.有望进一步通过安全性和有效性评估以推进临床转化.

Objective:To study the transdermal absorption of ingredients,therapeutic effect and biosafety of the new formula gel patch compound of the Xiaoyusan in osteoarthritis(OA)rats.Methods:The skin transdermal absorption process was simulat-ed by Franz diffusion cell method,and the new formula gel patch compound of the Xiaoyusan receiving solution was analyzed by UPLC-Q-TOF/MS.24 rats were divided into sham operation group,OA model group,positive control group(Flurbiprofen Cata-plasms)and experimental group(the new formula gel patch compound of the Xiaoyusan)with 6 rats in each group.All rats under-went anterior cruciate ligment transection(ACLT)except the sham operation group.The OA rat model was established by ACLT.One week after the model was made,the new formula gel patch compound of the Xiaoyusan was applied to the knee joint of the rat as an experimental drug.Orbital blood and knee joint specimens were collected after continuous treatment for 21 days,and hematoxylin-eosin(H&E)staining and safranin O-fast green(Safranin O)staining were used to analyze the severity of knee cartilage injury in each group.H&E staining was used to evaluate the severity of knee synovitis.The expression of collagen type Ⅱalpha 1(Col2a1),matrix metallopeptidase 13(MMP13),and caspase 3 in cartilage,as well as the expression of inducible nitric oxide synthase(iNOS)and tumour necrosis factor alpha(TNF-α)in synovium,was detected using immunohistochemistry in each group;enzyme linked immunosorbent assay(ELISA)was used to analyze the levels of serum inflammatory cytokines TNF-α and interleuin 17(IL-17)in each group.The tissue and organ structure of each group was analyzed by H&E staining to evaluate the biosafety.Results:(1)The new formula gel patch compound of the Xiaoyusan contain 28 prototype ingredients,in-cluding 6-methyl-rhein and rhein in imperial medicine Rhubarb.(2)After 21 days of external application treatment,both the new formula gel patch compound of the Xiaoyusan and Flurbiprofen Cataplasms can save articular cartilage injury and synovial inflam-mation in OA rats,and the therapeutic effect of the new formula gel patch compound of the Xiaoyusan is better.The expression of Col2a1 was significantly up-regulated,and the expressions of MMP13 and Caspase 3 were significantly inhibited(P<0.05).(3)The treatment of flurbiprofen gel paste and the new formula gel patch compound of the Xiaoyusan can alleviate synovial inflam-mation in rats.Immunohistochemical staining further indicated that the expression of TNF-α and iNOS in synovial membrane of rats in the new formula gel patch compound of the Xiaoyusan group was significantly down-regulated(P<0.05).(4)ELISA re-sults showed that the occurrence and development of OA and the treatment of the new formula gel patch compound of the Xiaoyu-san did not cause the up-regulation of systemic inflammatory factors TNF-α and IL-17.Meanwhile,after external treatment of the new formula gel patch compound of the Xiaoyusan,the microstructure of tissues and organs of rats in each group were normal and there was no obvious inflammatory infiltration.Conclusion:The new formula gel patch compound of the Xiaoyusan contains 6-methyl-rhein and rhein,which are found in rhubarb.The new formula gel patch compound of the Xiaoyusan can promote the syn-thesis of cartilage matrix,inhibit the apoptosis of chondrocytes and the expression of synovial inflammatory factors in the treatment of OA,and has good biosafety.It is expected to further promote clinical conversion through safety and efficacy evaluation.

张玉;杨然;刘芳;娄祺祺;金立伦;滕蔚然

上海交通大学医学院附属新华医院中医科,上海 200092上海交通大学医学院附属新华医院中医科,上海 200092上海交通大学医学院附属新华医院老年科,上海 200092上海交通大学医学院附属新华医院中医科,上海 200092上海交通大学医学院附属新华医院中医科,上海 200092上海交通大学医学院附属新华医院中医科,上海 200092

医药卫生

骨关节炎软骨损伤滑膜炎透皮消瘀散精简方新组方凝胶贴

Osteoarthritis(OA)Cartilage injurySynovitisTransdermal the new formula gel patch compound of the Xiaoyusan

《海南医科大学学报》 2026 (1)

10-19,10

上海市科委项目(20S21900200)上海市卫健委项目[ZY(2021-2023)-03-02-25,2024002] This study was supported by the Shanghai Science and Technology Commission Project(20S21900200)Shanghai Municipal Health Commission Project[ZY(2021-2023)-03-02-25,2024002]

10.13210/j.cnki.jhmu.20241106.004

评论